Serum cytokines in patients with Legionella pneumonia: Relative predominance of Th1-type cytokines

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 3, 1998, Pages 401-403

  Tateda, Kazuhiro ^a   Matsumoto, Tetsuya ^a   Ishii, Yoshikazu ^a   Furuya, Nobuhiko ^a   Ohno, Akira ^a   Miyazaki, Shuichi ^a   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12;

CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; PNEUMONIA; PRIORITY JOURNAL; SERUM; SHORT SURVEY;

EID: 0031859541     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.3.401-403.1998     Document Type: Short Survey

References (24)

1. Edelstein, P. H., and R. D. Meyer. 1994. Legionella pneumonias, p. 381-402. In J. E. Pennington (ed.), Respiratory infections: diagnosis and management. 3rd ed. Raven Press. New York, N.Y.
2. Engleberg, N. C., C. Carter, D. R. Weber, N. P. Cianciotto, and B. I. Eisenstein. 1989. DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity. Infect. Immun. 57:1263-1270.
3. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-2524.
4. Guler, M. L., J. D. Gorham, C. S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984-987.
5. Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of TH1 CD4+ T cells through IL-12 produced Listeria-induced macrophages. Science 260:547-549.
6. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62:2818-2824.
7. Jaufhac, B., M. Nowicki, N. Bornstein, O. Meunier, G. Prevost, Y. Piemont, J. Fleurette, and H. Monteil. 1992. Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification. J. Clin. Microbiol. 30:920-924.
8. Kirby, B. D., K. M. Snyder, R. D. Meyer, and S. M. Finegold. 1980. Legionnaire's disease: report of sixty-five nosocomially acquired cases and review of the literature. Medicine (Baltimore) 59:188-205.
9. Kitsukawa, K., A. Nakamoto, H. Koito, Y. Matsuda, A. Saito, and H. Yamamoto. 1995. Interferon-γ production by human T lymphocytes upon Legionella pneumophila stimulation in vitro. Clin. Exp. Immunol. 99:76-81.
10. Kohler, R. B., W. C. Winn, Jr., and L. J. Wheat. 1984. Onset and duration of urinary antigen exeretion in Legionnaires disease. J. Clin. Microbiol. 20: 605-607.
11. Lin, Y., M. Zhang, F. M. Hofman, J. Gong, and P. F. Barnes. 1996. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect. Immun. 64:1351-1356.
12. Lueey, D. R., M. Clerici, and G. M. Shearer. 1996. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9:532-562.
13. Marston, B. J., H. B. Lipman, and R. F. Breiman. 1994. Surveillance for Legionnaire's disease. Risk factors for morbidity and mortality. Arch. Intern. Med. 154:2417-2422.
14. Melby, P. C., F. Andrade-Narvaez, B. J. Darnell, and G. Valencia-Pacheco. 1996. In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. FEMS Immunol. Med. Microbiol. 15:101-107.
15. Morley, J. N., L. C. Smith, A. L. Baltch, and R. P. Smith. 1994. Recurrent infection due to Legionella pneumophila in a patient with AIDS. Clin. Infect. Dis. 19:1130-1132.
16. Naot, Y., A. Brown, E. M. Elder, J. Shonnard, B. J. Luft, and J. S. Remington. 1982. IgM and IgG antibody response in two immunosuppressed patients with Legionnaire's disease. Evidence of reactivation of latent infection. Am. J. Med. 73:791-794.
17. Nash, T. W., D. M. Libby, and M. A. Horwitz. 1988. IFN-γ activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J. Immunol. 140:3978-3981.
18. Newton, C. A., T. W. Klein, and H. Friedman. 1994. Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect. Immun. 62:4015-4020.
19. Noben-Trauth, N., P. Kropf, and I. Muller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271:987-990.
20. Romagnani, S. 1995. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15:121-129.
21. Romani, L., L. Menacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. E. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper 1 differentiation in murine candidiasis. J. Immunol. 153:2533-2543.
22. Sieling, P. A., and R. L. Modlin. 1994. Cytokine patterns at the site of mycobacterial infection. Immunobiology. 191:378-387.
23. Skerrett, S. J., and T. R. Martin. 1992. Recombinant murine interferon-γ reversibly activates rat alveolar macrophages to kill Legionella pneumophila. J. Infect. Dis. 166:1354-1361.
24. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.